OAB-052: Impact of chromosome 1 abnormalities on newly diagnosed multiple myeloma treated with proteasome inhibitor, immunomodulatory drug, and dexamethasone: analysis from the ENDURANCE ECOG-ACRIN E1A11 trialPrashant Kapoor, Shaji Kumar, Natalie S. Callander et al.|Clinical Lymphoma Myeloma & Leukemia|2021Cited by 16